Course of the Manic-Depressive Cycle and Changes Caused by Treatments

scientific article published on 01 July 1980

Course of the Manic-Depressive Cycle and Changes Caused by Treatments is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1055/S-2007-1019628
P953full work available at URLhttp://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-1019628.pdf
P698PubMed publication ID6108577

P2093author name stringL. Tondo
G. Serra
A. Kukopulos
D. Reginaldi
G. Floris
P. Laddomada
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)156-167
P577publication date1980-07-01
P1433published inPharmakopsychiatrie, Neuro-PsychopharmakologieQ27712617
P1476titleCourse of the manic-depressive cycle and changes caused by treatment
Course of the Manic-Depressive Cycle and Changes Caused by Treatments
P478volume13

Reverse relations

cites work (P2860)
Q52932623A meta-analysis of the use of typical antipsychotic agents in bipolar disorder.
Q41189037A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures
Q92892412A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder
Q22242646A systematic review of the evidence on the treatment of rapid cycling bipolar disorder
Q35236966Acute and long-term treatment of mania.
Q44804255Adjunct treatments in acute mania
Q36466842Adjunctive treatment of acute mania with risperidone versus typical antipsychotics: a retrospective study.
Q36551594Age transitions in the course of bipolar I disorder
Q44335284Alcohol dependence and mood disorders
Q42645137An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization
Q35664266Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians
Q38899735Antidepressant-Induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness
Q34448125Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice
Q73437213Antidepressant-associated mania in late life
Q60048075Antidepressants in bipolar depression: an enduring controversy
Q40095757Approaches to the Evaluation and Treatment of Rapid-Cycling Affective Illness
Q39305694Athanasios Koukopoulos' Psychiatry: The Primacy of Mania and the Limits of Antidepressants.
Q38873600Athanasios Koukopoulos' psychiatry: The primacy of mania and the uselessness of antidepressants
Q35073763Atypical antipsychotics and mood stabilization in bipolar disorder
Q50558688Bipolar II illness: course and outcome over a five-year period.
Q35017636Bipolar depression: management options
Q82235766Bipolar disorder
Q34977053Bipolar disorder detection, ascertainment, and treatment: primary care physician knowledge, attitudes, and awareness
Q26795404Bipolar disorder in women
Q34052830Bipolar disorder therapeutics: maintenance treatment
Q27010258Bipolar spectrum: a review of the concept and a vision for the future
Q33957680Bipolarity from ancient to modern times: conception, birth and rebirth
Q34547113Clinical correlates of therapeutic response in bipolar disorder
Q92061330Clinical use of lithium salts: guide for users and prescribers
Q33744368Comparative pharmacology of bipolar disorder and schizophrenia
Q35212332Concepts in the treatment of bipolar disorder.
Q40866452Continuation and maintenance pharmacotherapy for unipolar and bipolar mood disorders.
Q39178954Continuous circular cycling as a predictor of treatment response in bipolar disorders: a comprehensive review of the current literature
Q34108459Current concepts in rapid cycling bipolar disorder
Q35236993Current issues: women and bipolar disorder
Q34521351Current research on rapid cycling bipolar disorder and its treatment
Q41638850Depression and Mania in Bipolar Disorder
Q48057165Depression following mania
Q54146505Divalproate augmentation in lithium-resistant rapid cycling mania in four geriatric patients.
Q39410022Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression
Q42671085Do patients with borderline personality disorder belong to the bipolar spectrum?
Q44266754Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients
Q34217217ECNP Consensus Meeting March 2000 Nice: guidelines for investigating efficacy in bipolar disorder. European College of Neuropsychopharmacology
Q36442497Early improvement with lithium in classic mania and its association with later response
Q40736450Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients
Q33572123Empirical typology of bipolar I mood episodes
Q50858416Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?
Q73308911First International Exchange on Bipolar Disorder
Q41638900Free Interval Duration: Clinical Evidence of the Primary Role of Excitement in Bipolar Disorder
Q47407217Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France
Q39502405Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder.
Q34057133Functional impairment and cognition in bipolar disorder
Q35561522Gender differences in bipolar disorder
Q51891488Gender differences in major depressive disorder and bipolar disorder.
Q50881952Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores.
Q33920209Historical perspectives and natural history of bipolar disorder
Q37547264Identification of Susceptible Loci and Enriched Pathways for Bipolar II Disorder Using Genome-Wide Association Studies
Q34503731Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?
Q35212737Issues in the treatment of bipolar disorder
Q36233958Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study
Q36916509Longitudinal course of bipolar I disorder: duration of mood episodes
Q44464135Maintenance efficacy of divalproex in the prevention of bipolar depression
Q34106695Maintenance therapies for classic and other forms of bipolar disorder
Q35132693Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication
Q26852133Memantine: New prospective in bipolar disorder treatment
Q44266760Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling
Q34349641Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis
Q34106689Pharmacotherapy of depression and mixed states in bipolar disorder.
Q52918538Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients.
Q36123888Progression of female reproductive stages associated with bipolar illness exacerbation
Q34313479Psychotic and mood disorders associated with the perimenopausal period: epidemiology, aetiology and management
Q77993014Rapid cycling affective disorder: a descriptive study from North India
Q22242605Rapid cycling bipolar disorder - diagnostic concepts
Q36177621Rapid cycling bipolar disorder: clinical characteristics and treatment options
Q33768223Rapid-cycling bipolar disorder. An overview of research and clinical experience
Q35154713Rapid-cycling bipolar disorder: effects of long-term treatments
Q43931805Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers
Q35146063Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Q34106678Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders
Q35036680Redefining mood stabilization
Q77790335Response to lithium maintenance treatment in bipolar disorders: comparison of women and men
Q35884680Rethinking the treatment paradigm for bipolar depression: the importance of long-term management
Q40775549Retrospective controlled study of inpatient ECT: does it prevent suicide?
Q36581155Risk of Psychiatric Disorders Following Symptomatic Menopausal Transition: A Nationwide Population-Based Retrospective Cohort Study
Q31951578Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues
Q36096615Subthreshold bipolarity: diagnostic issues and challenges
Q31951593Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP).
Q28076486The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines
Q30583384The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Q33723078The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology
Q51789654The clinical history and costs associated with delayed diagnosis of bipolar disorder.
Q35142731The effect of lithium in bipolar disorder: a review of recent research evidence
Q63446703The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder
Q34185336The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence
Q41361361The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
Q33817419The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study
Q45959644The pharmacogenetics of lithium response depends upon clinical co-morbidity.
Q36170788The phenotypes of bipolar disorder: relevance for genetic investigations
Q37980516The role of antipsychotics in the management of fibromyalgia
Q33878237The role of gender in mixed mania
Q38025454The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence
Q33962900The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions
Q73617031The treatment of bipolar depression
Q39886182Transitions: Athanasios Koukopoulos [AθανάσιΟς κΟυκόπΟυλΟς], M.D. (1931-2013).
Q39287194Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?
Q37973144Treatment of mixed bipolar states
Q35613758Treatment of non-schizophrenic disorders: focus on atypical antipsychotics
Q34969649Treatment research in bipolar disorder: issues and recommendations
Q41127918Treatment-resistant bipolar depression
Q40089146Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications
Q39004427What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier?
Q38786807Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders
Q41733999Women's mental health in primary care. Depression, anxiety, somatization, eating disorders, and substance abuse
Q79351258[Treatment of bipolar disorders]

Search more.